Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules

被引:78
作者
Carlezon, WA
Konradi, C
机构
[1] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA
[2] McLean Hosp, Belmont, MA 02478 USA
关键词
addiction; psychotropic; developmental; exposure; rats;
D O I
10.1016/j.neuropharm.2004.06.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Children receive significant exposure to psychotropic drugs. Some psychiatric disorders are diagnosed and treated in children as young as 2 years old, resulting in exposure to prescription stimulants, antidepressants, and mood stabilizers during brain development. Difficulties in diagnoses at such young ages increase the likelihood that children who are not affected by these disorders receive drug exposure inadvertently. Additionally, the increased availability of caffeine-containing beverages in schools has facilitated exposure to this stimulant in children. However, the consequences of exposure to psychotropic drugs during brain development are not understood. When we exposed rats to the prescription stimulant methylphenidate during early adolescence, we discovered long-lasting behavioral and molecular alterations that were consistent with dramatic changes in the function of brain reward systems. In future work, it will be important to determine if other classes of psychotropic drugs cause these same effects, and whether these effects will also occur if drug exposure begins during other periods of development. Moreover, it will be critical to use more powerful behavioral methods that are sensitive to high-level aspects of motivation and cognitive function, and to establish causal links between developmental exposure-related alterations in these complex behaviors and specific alterations in the molecular biology of key brain regions. This approach may identify classes of psychotropic drugs that have high or low propensities to cause behavioral and molecular adaptations that endure into adulthood. It may also identify periods of development during which administration of these agents is particularly safe or risky. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:47 / 60
页数:14
相关论文
共 107 条
  • [1] Sex differences in dopamine receptor overproduction and elimination
    Andersen, SL
    Rutstein, M
    Benzo, JM
    Hostetter, JC
    Teicher, MH
    [J]. NEUROREPORT, 1997, 8 (06) : 1495 - 1498
  • [2] Altered responsiveness to cocaine in rats exposed to methylphenidate during development
    Andersen, SL
    Arvanitogiannis, A
    Pliakas, AM
    LeBlanc, C
    Carlezon, WA
    [J]. NATURE NEUROSCIENCE, 2002, 5 (01) : 13 - 14
  • [3] Protein-protein interactions as a target for drugs in proteomics
    Archakov, AI
    Govorun, VM
    Dubanov, AV
    Ivanov, YD
    Veselovsky, AV
    Lewi, P
    Janssen, P
    [J]. PROTEOMICS, 2003, 3 (04) : 380 - 391
  • [4] Atkins JB, 1999, SYNAPSE, V33, P118, DOI 10.1002/(SICI)1098-2396(199908)33:2<118::AID-SYN2>3.3.CO
  • [5] 2-C
  • [6] EVIDENCE THAT THE AVERSIVE EFFECTS OF OPIOID ANTAGONISTS AND KAPPA-AGONISTS ARE CENTRALLY MEDIATED
    BALSKUBIK, R
    HERZ, A
    SHIPPENBERG, TS
    [J]. PSYCHOPHARMACOLOGY, 1989, 98 (02) : 203 - 206
  • [7] A 'crash' course on psychostimulant withdrawal as a model of depression
    Barr, AM
    Markou, A
    Phillips, AG
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (10) : 475 - 482
  • [8] CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli
    Barrot, M
    Olivier, JDA
    Perrotti, LI
    DiLeone, RJ
    Berton, O
    Eisch, AJ
    Impey, S
    Storm, DR
    Neve, RL
    Yin, JC
    Zachariou, V
    Nestler, EJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) : 11435 - 11440
  • [9] CHRONIC MORPHINE IMPAIRS AXOPLASMIC-TRANSPORT IN THE RAT MESOLIMBIC DOPAMINE SYSTEM
    BEITNERJOHNSON, D
    NESTLER, EJ
    [J]. NEUROREPORT, 1993, 5 (01) : 57 - 60
  • [10] Caffeine dependence in teenagers
    Bernstein, GA
    Carroll, ME
    Thuras, PD
    Cosgrove, KP
    Roth, ME
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2002, 66 (01) : 1 - 6